157 related articles for article (PubMed ID: 18650843)
21. LEDGF/p75 has increased expression in blasts from chemotherapy-resistant human acute myelogenic leukemia patients and protects leukemia cells from apoptosis in vitro.
Huang TS; Myklebust LM; Kjarland E; Gjertsen BT; Pendino F; Bruserud Ø; Døskeland SO; Lillehaug JR
Mol Cancer; 2007 Apr; 6():31. PubMed ID: 17451600
[TBL] [Abstract][Full Text] [Related]
22. A novel ring-substituted diindolylmethane,1,1-bis[3'-(5-methoxyindolyl)]-1-(p-t-butylphenyl) methane, inhibits extracellular signal-regulated kinase activation and induces apoptosis in acute myelogenous leukemia.
Contractor R; Samudio IJ; Estrov Z; Harris D; McCubrey JA; Safe SH; Andreeff M; Konopleva M
Cancer Res; 2005 Apr; 65(7):2890-8. PubMed ID: 15805291
[TBL] [Abstract][Full Text] [Related]
23. c-Jun NH2-terminal kinase activation contributes to hypoxia-inducible factor 1alpha-dependent P-glycoprotein expression in hypoxia.
Comerford KM; Cummins EP; Taylor CT
Cancer Res; 2004 Dec; 64(24):9057-61. PubMed ID: 15604272
[TBL] [Abstract][Full Text] [Related]
24. Signal transduction pathways in Burkitt's lymphoma cell lines BL41 and DG75 with different sensitivity to doxorubicin.
Shlapatska LM; Berdova GG; Kovalevska LM; Kulyk GI; Klein G; Sidorenko SP; Chekhun VF
Exp Oncol; 2004 Sep; 26(3):210-6. PubMed ID: 15494689
[TBL] [Abstract][Full Text] [Related]
25. MiR-15a-5p Confers Chemoresistance in Acute Myeloid Leukemia by Inhibiting Autophagy Induced by Daunorubicin.
Bollaert E; Claus M; Vandewalle V; Lenglez S; Essaghir A; Demoulin JB; Havelange V
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34068078
[TBL] [Abstract][Full Text] [Related]
26. The cell polarity PTK7 receptor acts as a modulator of the chemotherapeutic response in acute myeloid leukemia and impairs clinical outcome.
Prebet T; Lhoumeau AC; Arnoulet C; Aulas A; Marchetto S; Audebert S; Puppo F; Chabannon C; Sainty D; Santoni MJ; Sebbagh M; Summerour V; Huon Y; Shin WS; Lee ST; Esterni B; Vey N; Borg JP
Blood; 2010 Sep; 116(13):2315-23. PubMed ID: 20558616
[TBL] [Abstract][Full Text] [Related]
27. A crosstalk between the Wnt and the adhesion-dependent signaling pathways governs the chemosensitivity of acute myeloid leukemia.
De Toni F; Racaud-Sultan C; Chicanne G; Mas VM; Cariven C; Mesange F; Salles JP; Demur C; Allouche M; Payrastre B; Manenti S; Ysebaert L
Oncogene; 2006 May; 25(22):3113-22. PubMed ID: 16407823
[TBL] [Abstract][Full Text] [Related]
28. Pleiotropic effects of spongean alkaloids on mechanisms of cell death, cell cycle progression and DNA damage response (DDR) of acute myeloid leukemia (AML) cells.
Stuhldreier F; Kassel S; Schumacher L; Wesselborg S; Proksch P; Fritz G
Cancer Lett; 2015 May; 361(1):39-48. PubMed ID: 25697484
[TBL] [Abstract][Full Text] [Related]
29. DNA-PKcs-mediated transcriptional regulation of TOP2B drives chemoresistance in acute myeloid leukemia.
Mishra SV; Banerjee A; Sarkar D; Thangarathnam V; Bagal B; Hasan SK; Dutt S
J Cell Sci; 2024 Feb; 137(3):. PubMed ID: 38240344
[TBL] [Abstract][Full Text] [Related]
30. Musashi-2 Silencing Exerts Potent Activity against Acute Myeloid Leukemia and Enhances Chemosensitivity to Daunorubicin.
Han Y; Ye A; Zhang Y; Cai Z; Wang W; Sun L; Jiang S; Wu J; Yu K; Zhang S
PLoS One; 2015; 10(8):e0136484. PubMed ID: 26308531
[TBL] [Abstract][Full Text] [Related]
31. Twist confers chemoresistance to anthracyclines in bladder cancer through upregulating P-glycoprotein.
Chen Y; Li L; Zeng J; Wu K; Zhou J; Guo P; Zhang D; Xue Y; Liang L; Wang X; Chang LS; He D
Chemotherapy; 2012; 58(4):264-72. PubMed ID: 22986993
[TBL] [Abstract][Full Text] [Related]
32. Tetraspanin CD82 drives acute myeloid leukemia chemoresistance by modulating protein kinase C alpha and β1 integrin activation.
Floren M; Restrepo Cruz S; Termini CM; Marjon KD; Lidke KA; Gillette JM
Oncogene; 2020 May; 39(19):3910-3925. PubMed ID: 32203165
[TBL] [Abstract][Full Text] [Related]
33. TRIM31 promotes acute myeloid leukemia progression and sensitivity to daunorubicin through the Wnt/β-catenin signaling.
Xiao Y; Deng T; Ming X; Xu J
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32232394
[TBL] [Abstract][Full Text] [Related]
34. Targeting the MTF2-MDM2 Axis Sensitizes Refractory Acute Myeloid Leukemia to Chemotherapy.
Maganti HB; Jrade H; Cafariello C; Manias Rothberg JL; Porter CJ; Yockell-Lelièvre J; Battaion HL; Khan ST; Howard JP; Li Y; Grzybowski AT; Sabri E; Ruthenburg AJ; Dilworth FJ; Perkins TJ; Sabloff M; Ito CY; Stanford WL
Cancer Discov; 2018 Nov; 8(11):1376-1389. PubMed ID: 30115703
[TBL] [Abstract][Full Text] [Related]
35. Heme oxygenase-1 plays a crucial role in chemoresistance in acute myeloid leukemia.
Zhe N; Wang J; Chen S; Lin X; Chai Q; Zhang Y; Zhao J; Fang Q
Hematology; 2015 Aug; 20(7):384-91. PubMed ID: 26218201
[TBL] [Abstract][Full Text] [Related]
36. Implication of radical oxygen species in ceramide generation, c-Jun N-terminal kinase activation and apoptosis induced by daunorubicin.
Mansat-de Mas V; Bezombes C; Quillet-Mary A; Bettaïeb A; D'orgeix AD; Laurent G; Jaffrézou JP
Mol Pharmacol; 1999 Nov; 56(5):867-74. PubMed ID: 10531389
[TBL] [Abstract][Full Text] [Related]
37. c-Jun N-Terminal Kinase Inactivation by Mitogen-Activated Protein Kinase Phosphatase 1 Determines Resistance to Taxanes and Anthracyclines in Breast Cancer.
Rincón R; Zazo S; Chamizo C; Manso R; González-Alonso P; Martín-Aparicio E; Cristóbal I; Cañadas C; Perona R; Lluch A; Eroles P; García-Foncillas J; Albanell J; Rovira A; Madoz-Gúrpide J; Rojo F
Mol Cancer Ther; 2016 Nov; 15(11):2780-2790. PubMed ID: 27599524
[TBL] [Abstract][Full Text] [Related]
38. Heme oxygenase-1 suppresses the apoptosis of acute myeloid leukemia cells via the JNK/c-JUN signaling pathway.
Lin X; Fang Q; Chen S; Zhe N; Chai Q; Yu M; Zhang Y; Wang Z; Wang J
Leuk Res; 2015 May; 39(5):544-52. PubMed ID: 25828744
[TBL] [Abstract][Full Text] [Related]
39. The natural alkaloid Jerantinine B has activity in acute myeloid leukemia cells through a mechanism involving c-Jun.
Alhuthali HM; Bradshaw TD; Lim KH; Kam TS; Seedhouse CH
BMC Cancer; 2020 Jul; 20(1):629. PubMed ID: 32635894
[TBL] [Abstract][Full Text] [Related]
40. The ROS/SUMO axis contributes to the response of acute myeloid leukemia cells to chemotherapeutic drugs.
Bossis G; Sarry JE; Kifagi C; Ristic M; Saland E; Vergez F; Salem T; Boutzen H; Baik H; Brockly F; Pelegrin M; Kaoma T; Vallar L; Récher C; Manenti S; Piechaczyk M
Cell Rep; 2014 Jun; 7(6):1815-23. PubMed ID: 24910433
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
